ReviewCureus2025
3D Bioprinting for Custom Bone Grafts in Orthopaedic Trauma: Current Advances and Clinical Translation.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic bone loss in orthopaedic trauma presents significant clinical challenges, particularly arising from high-energy injuries, open fractures with segmental defects, and blast trauma, where bone loss exceeds the critical size for spontaneous healing. Traditional management strategies, including autografts, allografts, and the Masquelet-induced membrane technique, are associated with limitations such as donor site morbidity, prolonged treatment duration, multiple surgical procedures, and suboptimal outcomes. Three-dimensional (3D) bioprinting technology has emerged as a promising solution for fabricating patient-specific bone grafts tailored to individual defect geometry and mechanical requirements. This narrative review examines current advances in 3D bioprinting specifically for orthopaedic trauma applications, focusing on technologies relevant to long bone reconstruction, load-bearing requirements, and complex fracture management. We analyze various bioprinting modalities, including extrusion-based and stereolithography techniques, alongside biomaterial developments in bioceramics, biodegradable polymers, and mechanically competent composite scaffolds. Clinical applications in femoral and tibial segmental defects, periarticular fractures, and combat-related extremity injuries are reviewed, with emphasis on preclinical large animal models and early clinical experiences. Critical challenges specific to orthopaedic trauma, including mechanical loading demands, infection risk in contaminated wounds, and integration with existing fixation systems, are discussed. This review examines emerging innovations, such as in situ bioprinting for intraoperative graft fabrication and personalized approaches incorporating patient-derived cells and growth factors. As bioprinting technology continues to mature, integration into orthopaedic trauma protocols promises to reduce treatment complexity, accelerate healing, and improve functional outcomes for patients with devastating skeletal injuries requiring advanced reconstructive solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.